| 标题 |
 US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Locally Advanced or Metastatic Breast Cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of clinical oncology : official journal of the American Society of Clinical Oncology 作者：Wedam S; Narayan P; Gittleman H; Cheng J; Bhatnagar V; et al 出版日期：2025/10/01 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
cdercder
Nole
Dean
xing_xing
aaaa
XX
学术文献互助
8R60d8
DOC_XIONG
OK
sagitar
修仙中
小鱼爱吃肉
馨馨的科科
bai
huang
6666
arniu2008
初景
皖公网安备34019202002308
